Goldman Sachs’s Amplify Treatments, Testing and Advancements ETF GERM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-10,372
Closed -$203K 6012
2023
Q4
$203K Sell
10,372
-27,168
-72% -$474K ﹤0.01% 5147
2023
Q3
$672K Sell
37,540
-25,386
-40% -$496K ﹤0.01% 4499
2023
Q2
$1.3M Buy
62,926
+32,376
+106% +$678K ﹤0.01% 4172
2023
Q1
$625K Sell
30,550
-34,266
-53% -$767K ﹤0.01% 4707
2022
Q4
$1.45M Buy
64,816
+26,682
+70% +$601K ﹤0.01% 4169
2022
Q3
$791K Buy
38,134
+11,074
+41% +$269K ﹤0.01% 4680
2022
Q2
$629K Sell
27,060
-45,638
-63% -$1.09M ﹤0.01% 4923
2022
Q1
$1.99M Buy
72,698
+27,295
+60% +$769K ﹤0.01% 4265
2021
Q4
$1.62M Sell
45,403
-798
-2% -$29.9K ﹤0.01% 4421
2021
Q3
$1.9M Buy
46,201
+27,649
+149% +$1.17M ﹤0.01% 4253
2021
Q2
$742K Sell
18,552
-10,709
-37% -$399K ﹤0.01% 4976
2021
Q1
$1.04M Hold
29,261
﹤0.01% 4578
2020
Q4
$910K Hold
29,261
﹤0.01% 4255
2020
Q3
$809K Buy
+29,261
New +$860K ﹤0.01% 4220

Other funds holding GERM